Commonwealth Equity Services’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,353
Closed -$239K 3839
2022
Q3
$239K Hold
13,353
﹤0.01% 3015
2022
Q2
$165K Hold
13,353
﹤0.01% 3262
2022
Q1
$177K Sell
13,353
-225
-2% -$3.02K ﹤0.01% 3374
2021
Q4
$211K Sell
13,578
-538
-4% -$10.3K ﹤0.01% 3262
2021
Q3
$316K Buy
14,116
+2,038
+17% +$44.7K ﹤0.01% 2874
2021
Q2
$275K Buy
12,078
+500
+4% +$10.5K ﹤0.01% 2987
2021
Q1
$238K Buy
11,578
+938
+9% +$21.4K ﹤0.01% 2983
2020
Q4
$293K Sell
10,640
-1,000
-9% -$19.5K ﹤0.01% 2605
2020
Q3
$163K Buy
11,640
+1,940
+20% +$36.1K ﹤0.01% 2789
2020
Q2
$200K Buy
+9,700
New +$132K ﹤0.01% 2608

Other funds holding MYOV

Commonwealth Equity Services's MYOV Position: Q4 2022 in Review

Commonwealth Equity Services sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 13,353 shares — an estimated $239K sold.

Commonwealth Equity Services first reported a position in MYOV in Q2 2020 and held it in 10 quarters. The position peaked at $316K in Q3 2021. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Commonwealth Equity Services reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 13,353 Myovant Sciences Ltd. shares in Q4 2022, an estimated $239K.
  • Commonwealth Equity Services first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 10 quarters.
  • Commonwealth Equity Services's Myovant Sciences Ltd. position peaked at $316K in Q3 2021.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Commonwealth Equity Services's 13F filing for Q4 2022, filed 7 Feb 2023.